Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 842970-08-5 | MDL No. : | MFCD05668679 |
Formula : | C14H22N2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MVPDGGMRKWOGHJ-UHFFFAOYSA-N |
M.W : | 218.34 | Pubchem ID : | 3158971 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.57 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 74.16 |
TPSA : | 29.26 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.59 cm/s |
Log Po/w (iLOGP) : | 2.59 |
Log Po/w (XLOGP3) : | 2.88 |
Log Po/w (WLOGP) : | 2.51 |
Log Po/w (MLOGP) : | 2.55 |
Log Po/w (SILICOS-IT) : | 2.58 |
Consensus Log Po/w : | 2.62 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.09 |
Solubility : | 0.178 mg/ml ; 0.000817 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.15 |
Solubility : | 0.153 mg/ml ; 0.000701 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.74 |
Solubility : | 0.0401 mg/ml ; 0.000184 mol/l |
Class : | Soluble |
PAINS : | 1.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.86 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
[ 328289-91-4 ]
4-((2,6-Dimethylpiperidin-1-yl)methyl)aniline
Similarity: 1.00
[ 937669-68-6 ]
3-((2-Methylpiperidin-1-yl)methyl)aniline
Similarity: 0.97
[ 29608-05-7 ]
4-(Piperidin-1-ylmethyl)aniline
Similarity: 0.91
[ 328289-91-4 ]
4-((2,6-Dimethylpiperidin-1-yl)methyl)aniline
Similarity: 1.00
[ 937669-68-6 ]
3-((2-Methylpiperidin-1-yl)methyl)aniline
Similarity: 0.97
[ 328289-91-4 ]
4-((2,6-Dimethylpiperidin-1-yl)methyl)aniline
Similarity: 1.00
[ 937669-68-6 ]
3-((2-Methylpiperidin-1-yl)methyl)aniline
Similarity: 0.97
[ 29608-05-7 ]
4-(Piperidin-1-ylmethyl)aniline
Similarity: 0.91
[ 328289-91-4 ]
4-((2,6-Dimethylpiperidin-1-yl)methyl)aniline
Similarity: 1.00
[ 937669-68-6 ]
3-((2-Methylpiperidin-1-yl)methyl)aniline
Similarity: 0.97
[ 328289-91-4 ]
4-((2,6-Dimethylpiperidin-1-yl)methyl)aniline
Similarity: 1.00
[ 937669-68-6 ]
3-((2-Methylpiperidin-1-yl)methyl)aniline
Similarity: 0.97
[ 29608-05-7 ]
4-(Piperidin-1-ylmethyl)aniline
Similarity: 0.91
[ 328289-91-4 ]
4-((2,6-Dimethylpiperidin-1-yl)methyl)aniline
Similarity: 1.00
[ 937669-68-6 ]
3-((2-Methylpiperidin-1-yl)methyl)aniline
Similarity: 0.97